{"id":13966,"date":"2026-04-01T15:18:25","date_gmt":"2026-04-01T22:18:25","guid":{"rendered":"https:\/\/ameripharmainfusioncenter.com\/?p=13966"},"modified":"2026-04-01T17:13:31","modified_gmt":"2026-04-02T00:13:31","slug":"iv-infusion-cost-remicade-vyvgart-comparison-aic","status":"publish","type":"post","link":"https:\/\/ameripharmainfusioncenter.com\/zh\/iv-infusion-cost-remicade-vyvgart-comparison-aic\/","title":{"rendered":"\u9759\u8109\u8f93\u6db2\u8d39\u7528\uff1aRemicade\u3001Vyvgart \u548c\u5176\u4ed6\u7279\u6b8a\u6cbb\u7597\u7684\u5b9e\u9645\u8d39\u7528"},"content":{"rendered":"\n

Understanding IV infusion costs isn’t just about the drug price; it’s about where you receive treatment. Patients receiving infusions at hospital outpatient departments pay 2.5 to 7 times more than those treated at specialty infusion centers, even for the exact same medications.<\/p>\n\n\n\n

\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\tGet Financial Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\tSchedule a Consultation<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n

If you’re researching the cost of IV infusion therapy, you’re likely facing a recent diagnosis or evaluating treatment options for a chronic condition. This guide breaks down real-world costs for common infusion medications like Remicade and Vyvgart, explains why location matters more than you think, and shows you how to reduce your out-of-pocket expenses without compromising care quality.<\/p>\n\n\n\n

Primary Cost Comparison: Hospital vs. Specialty Infusion Center<\/strong><\/h2>\n\n\n\n

The single biggest factor determining your infusion cost isn’t the drug itself; it’s where the infusion takes place. According to a 2024 study published in the New England Journal of Medicine<\/em> analyzing over 4.7 million infusion visits, hospitals impose markup rates between 120% and 630%<\/strong> above drug acquisition costs, while independent physician practices and specialty infusion centers operate at near-cost pricing with markups around 12%<\/strong> [1]. <\/p>\n\n\n\n

IV Infusion Cost Comparison by Setting<\/strong> <\/p>\n\n\n\n

Setting<\/strong><\/td>Drug Cost<\/strong><\/td>Facility Fee<\/strong><\/td>Administration<\/strong><\/td>Total Per Treatment<\/strong><\/td>Markup vs. Acquisition<\/strong><\/td><\/tr>
Hospital-based (HOPD)<\/td>$1,500 – $3,000<\/td>$800 – $2,500<\/td>$200 – $500<\/td>$2,500 – $6,000<\/strong><\/td>276-289%<\/td><\/tr>
Hospital outpatient<\/td>$1,200 – $2,500<\/td>$500 – $1,500<\/td>$150 – $400<\/td>$1,850 – $4,400<\/strong><\/td>244%<\/td><\/tr>
Specialty infusion center<\/td>$900 – $1,500<\/td>$0<\/td>$100 – $250<\/td>$1,000 – $1,750<\/strong><\/td>~12%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Source: NEJM Hospital Prices for Physician-Administered Drugs (2024); Third Way Hospital Pricing Report (2025) [1,2]<\/em><\/p>\n\n\n\n

Why Hospital-Based Infusions Cost More<\/strong><\/h3>\n\n\n\n

Three factors drive higher hospital costs:<\/p>\n\n\n\n

    \n
  1. Facility Fees:<\/strong> Hospitals charge separate “facility fees” ranging from $800 to $2,500 per visit to cover overhead costs like building maintenance, equipment, and administrative staff. Specialty infusion centers don’t impose these fees [3].<\/li>\n\n\n\n
  2. Market Power Through Consolidation:<\/strong> As hospital systems acquire competing facilities and physician practices, they gain negotiating leverage with insurers. Research from Third Way shows that patients pay 3 to 7 times more<\/strong> for the same infusion when their physician’s office is owned by a hospital system [2].<\/li>\n\n\n\n
  3. 340B Program Misalignment:<\/strong> Approximately one-third of hospitals qualify for the federal 340B Drug Pricing Program, which provides discounts averaging 35% off wholesale drug costs. However, these hospitals aren’t required to pass savings to patients. The NEJM study found 340B-eligible hospitals retain 64.3%<\/strong> of insurer drug spending through markups, compared to 19.1% retained by physician practices [1].<\/li>\n<\/ol>\n\n\n\n

    Breaking Down Remicade Infusion Costs<\/strong><\/h2>\n\n\n\n

    Remicade (infliximab) is one of the most commonly prescribed biologic therapies for autoimmune conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis, and psoriatic arthritis. Understanding its cost structure helps patients anticipate expenses.<\/p>\n\n\n\n

    Remicade Pricing Components<\/strong><\/h3>\n\n\n\n

    Drug Acquisition Cost:<\/strong><\/p>\n\n\n\n